HKG: 1521

Frontage Laboratories Inc., (HKG: 1521), a Contract Research Organization (CRO) with operations in Pennsylvania, Suzhou, and Shanghai, has announced the completion of its acquisition of the Bioanalytical and Drug Metabolism & Pharmacokinetics (DMPK) businesses from Italy-based CRO Accelera S.r.l. The specifics of the deal were not disclosed. This acquisition is…